91 related articles for article (PubMed ID: 10910066)
1. Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle.
Iancu C; Mistry SJ; Arkin S; Atweh GF
Cancer Res; 2000 Jul; 60(13):3537-41. PubMed ID: 10910066
[TBL] [Abstract][Full Text] [Related]
2. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy.
Mistry SJ; Atweh GF
Mt Sinai J Med; 2002 Oct; 69(5):299-304. PubMed ID: 12415323
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure.
Mistry SJ; Bank A; Atweh GF
Mol Cancer Res; 2007 Aug; 5(8):773-82. PubMed ID: 17670914
[TBL] [Abstract][Full Text] [Related]
4. The role of stathmin in the regulation of the cell cycle.
Rubin CI; Atweh GF
J Cell Biochem; 2004 Oct; 93(2):242-50. PubMed ID: 15368352
[TBL] [Abstract][Full Text] [Related]
5. Effects of stathmin inhibition on the mitotic spindle.
Iancu C; Mistry SJ; Arkin S; Wallenstein S; Atweh GF
J Cell Sci; 2001 Mar; 114(Pt 5):909-16. PubMed ID: 11181174
[TBL] [Abstract][Full Text] [Related]
6. Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth.
Kinoshita I; Leaner V; Katabami M; Manzano RG; Dent P; Sabichi A; Birrer MJ
Oncogene; 2003 May; 22(18):2710-22. PubMed ID: 12743595
[TBL] [Abstract][Full Text] [Related]
7. Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells.
Jeha S; Luo XN; Beran M; Kantarjian H; Atweh GF
Cancer Res; 1996 Mar; 56(6):1445-50. PubMed ID: 8640838
[TBL] [Abstract][Full Text] [Related]
8. [Significance of stathmin gene overexpression in osteosarcoma cells].
Zhang HZ; Gao P; Yan L; Lin F
Ai Zheng; 2004 May; 23(5):493-6. PubMed ID: 15142441
[TBL] [Abstract][Full Text] [Related]
9. Development of ribozymes that target stathmin, a major regulator of the mitotic spindle.
Mistry SJ; Benham CJ; Atweh GF
Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):41-9. PubMed ID: 11258620
[TBL] [Abstract][Full Text] [Related]
10. Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
Kelling J; Sullivan K; Wilson L; Jordan MA
Cancer Res; 2003 Jun; 63(11):2794-801. PubMed ID: 12782584
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer.
Mistry SJ; Atweh GF
Mol Cancer Ther; 2006 Dec; 5(12):3248-57. PubMed ID: 17172428
[TBL] [Abstract][Full Text] [Related]
12. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.
Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL
Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650
[TBL] [Abstract][Full Text] [Related]
13. Requirement of a functional spindle checkpoint for arsenite-induced apoptosis.
Wu YC; Yen WY; Yih LH
J Cell Biochem; 2008 Oct; 105(3):678-87. PubMed ID: 18668508
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene.
Miyashita H; Kanemura M; Yamazaki T; Abe M; Sato Y
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):878-84. PubMed ID: 15031128
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of the mitotic spindle--potential therapeutic targets.
Miyamoto DT; Perlman ZE; Mitchison TJ; Shirasu-Hiza M
Prog Cell Cycle Res; 2003; 5():349-60. PubMed ID: 14593729
[TBL] [Abstract][Full Text] [Related]
16. Bistratene A induces a microtubule-dependent block in cytokinesis and altered stathmin expression in HL60 cells.
Johnson WE; Watters DJ; Suniara RK; Brown G; Bunce CM
Biochem Biophys Res Commun; 1999 Jun; 260(1):80-8. PubMed ID: 10381347
[TBL] [Abstract][Full Text] [Related]
17. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
19. Stathmin inhibition enhances okadaic acid-induced mitotic arrest: a potential role for stathmin in mitotic exit.
Mistry SJ; Atweh GF
J Biol Chem; 2001 Aug; 276(33):31209-15. PubMed ID: 11418586
[TBL] [Abstract][Full Text] [Related]
20. Stathmin 1: a novel therapeutic target for anticancer activity.
Rana S; Maples PB; Senzer N; Nemunaitis J
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1461-70. PubMed ID: 18759697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
